Carlyle in talks to buy Baxter's kidney care unit, source says
WEBJul 5, 2024 · Private equity firm Carlyle Group is in exclusive talks to acquire Baxter International's kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar with the matter...
Carlyle Group (CG) Eyes Buyout of Baxter's Kidney Care Unit
WEBJul 9, 2024 · Carlyle Group (CG) is in talks to acquire Baxter's kidney care unit. The companies started exclusive negotiations in late June and an agreement could be announced as soon as this week.
Carlyle Group Eyes Buyout of Baxter's Kidney Care Unit
WEBJul 9, 2024 · Carlyle Group (NASDAQ:CG) is considering acquiring Baxter International 's (NYSE:BAX) kidney care spinoff, Vantive, in a deal valued at more than $4 billion, including debt. The news was first...
Ares, HPS Line Up $3 Billion Debt for Carlyle’s Baxter Unit Bid
WEB5 days ago · Carlyle has been in talks to buy the Vantive kidney-care unit Carveouts have been an active opportunity for private credit By John Sage July 23, 2024 at 9:53 AM PDT Updated on July 23, 2024 at 10: ...
Carlyle in Advanced Talks to Acquire Baxter’s Vantive
WEBJul 11, 2024 · The Details: Reporter Laura Cooper was first to report that Carlyle Group [CG] is in talks to acquire Baxter ’s kidney-care spinoff Vantive. According to The Wall Street Journal report, the parties entered exclusive negotiations in late June and a deal could be announced in the coming weeks.
Carlyle Eyes $4B Acquisition Of Baxter's Kidney-Care Unit …
WEBCarlyle Group (NYSE:CG) is reportedly in exclusive talks to acquire Baxter International Inc.’s (NYSE:BAX) kidney-care spinoff, Vantive, in a deal valued at over $4 billion, including...
Carlyle in talks to buy Baxter's kidney care unit, source says
WEB(Reuters) - Private equity firmCarlyle Group is in exclusive talks to acquire Baxter International 's kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar...
Carlyle's eyes Baxter's Vantive in kidney play - Axios
WEBJul 8, 2024 · Carlyle's eyes Baxter's Vantive in kidney play. Claire Rychlewski. Jul 8, 2024. Illustration: Sarah Grillo/Axios. Carlyle is in talks to buy medical device giant Baxter's kidney care spinoff Vantive for more than $4 billion, including debt, WSJ reports.
Baxter gains amid report in talks to sell kidney care spinoff to ...
WEBBaxter International (NYSE:BAX) rose 4% after a report that private equity firm Carlyle Group (CG) is in talks to acquire the kidney care spinoff for more than $4 billion, including debt.
Baxter's kidney business could go to Carlyle for over $4B: report
WEBJul 8, 2024 · Private-equity firm Carlyle Group is in talks to buy Baxter International's spinoff kidney business, Vantive, The Wall Street Journal reports. The sale of the business could go for more...
- Some results have been removed
Skip to content